Deal Makers of Japan, Volume 3
The Deal Makers of Japan series aims to bridge the gap and offer insight to a global biopharma audience to the Japanese pharma industry.
Asian Capabilities, Insight, Market Trends, White Papers
Insight
Insight, Market Trends, White Papers
RNA Therapeutics Landscape Overview
While these key pillars are not exhaustive and approaches may overlap between multiple, these areas have seen a great deal of innovation and attention from strategics and investors as a result.
Insight, Market Conditions, Market Trends, Quarterly Reports
2022 Year-In-Review Report: Global Trends in Biopharma Transactions
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2022 Year In Review Report applies the latest data to analyze current activities in the life sciences deal landscape.